
BPC-157 + TB-500 Blend (10mg)
Especificaciones técnicas
| Pureza (HPLC) | ≥99% (HPLC) |
| Número CAS | 137525-51-0 |
| Forma | White lyophilized powder |
| Almacenamiento | -20°C |
| Secuencia | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Peso molecular | 1,419.53 g/mol |
| Forma salina | Acetate |
| Solubilidad | Soluble in water, DMSO |
BPC-157 + TB-500 Blend (10mg)
Precio de lista en EUR · HU, SK, CZ, PL
- Eurozone (EUR)76,50 EUR
- Hungría (HU)76,50 EUR≈ 30 600 Ft
- Eslovaquia (SK)76,50 EUR
- Chequia (CZ)76,50 EUR≈ 1 913 Kč
- Polonia (PL)76,50 EUR≈ 325,13 zł
Mismo precio de lista en EUR para envío a Hungría, Eslovaquia, República Checa y Polonia. El pago se cobra en EUR.
HUF/CZK/PLN indicativos convertidos desde EUR; Eslovaquia usa EUR. Tasas aproximadas. Cobro en EUR.
Synergistic blend of BPC-157 and TB-500 for comprehensive tissue repair research. 10mg total vial.
Estrictamente para investigación de laboratorio.
No apto para consumo humano, uso veterinario ni diagnóstico.
From the Peptide Explorer
A 15-amino-acid gastric pentadecapeptide with remarkable stability in the GI tract. One of the most extensively studied peptides in regenerative research with over 100 publications spanning wound healing, angiogenesis, tendon repair, and cytoprotection.
Key Mechanisms
- ›VEGFR2 upregulation
- ›FAK-paxillin pathway activation
- ›ERK1/2 signaling
- ›NO system modulation
- ›Growth hormone receptor upregulation
Primary Research Areas
- ›Wound healing
- ›Tendon & ligament repair
- ›GI cytoprotection
- ›Angiogenesis
- ›Neuroprotection
Key Research Findings
- Accelerated tendon-to-bone healing in rat models (Chang et al., 2014)
- Promoted angiogenesis via VEGFR2 in endothelial cells (Hsieh et al., 2017)
- Demonstrated GI cytoprotective effects against NSAID damage (Sikiric et al., 2018)
Research Overview
A 15-amino-acid gastric pentadecapeptide with remarkable stability in the GI tract. One of the most extensively studied peptides in regenerative research with over 100 publications spanning wound healing, angiogenesis, tendon repair, and cytoprotection.
Origin: Derived from human gastric juice protein BPC
Mechanism of Action
- VEGFR2 upregulation
- FAK-paxillin pathway activation
- ERK1/2 signaling
- NO system modulation
- Growth hormone receptor upregulation
Primary Research Areas
- Wound healing
- Tendon & ligament repair
- GI cytoprotection
- Angiogenesis
- Neuroprotection
Key Published Findings
- Accelerated tendon-to-bone healing in rat models (Chang et al., 2014)
- Promoted angiogenesis via VEGFR2 in endothelial cells (Hsieh et al., 2017)
- Demonstrated GI cytoprotective effects against NSAID damage (Sikiric et al., 2018)
Research Protocol
Commonly studied routes: Subcutaneous, Oral. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized, 2-8°C reconstituted (3-4 weeks)
Important Notice
BPC-157 + TB-500 Blend (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Especificaciones de investigación
Synthesized for strict analytical consistency. Verified via HPLC/MS.Ver estándares de calidad →
Manipulación y almacenamiento
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water, DMSO